The purpose of this review is to identify the common causes of nonmalignant chronic pain in people with dementia, discuss methods for determining the level of pain in patients who are nonverbal, and evaluate pharmacologic treatment for nonmalignant chronic pain.
Wolf-Klein GP, Silverstone FA, Brod MS, et al.: Are Alzheimer patients healthier?J Am Geriatr Soc.1988; 36(3): 219-224.
2.
Magni G, Marchetti M, Moreschi C, et al.: Chronic musculoskeletal pain and depressive symptoms in the National Health and Nutrition Examination. Pain.1993; 53(2): 163-168.
3.
Mobily PR, Herr KA, Clark MK: An epidemiologic analysis of pain in the elderly: The Iowa 65+ Rural Health Study. J Aging Health. 1994; 6: 139-154.
4.
Crook J, Rideout E, Browne G: The prevalence of pain complaints in a general population. Pain. 1984; 18(3): 299-299.
5.
Ferrell BA, Ferrell BR, Osterweil D: Pain in the nursing home. J Am Geriatr Soc.1990; 38(4): 409-414.
Kaasalainen SJ, Robinson LK, Hartley T, et al.: The assessment of pain in the cognitively impaired elderly: A literature review. Perspectives. 1998; 22(2): 2-8.
8.
Takeshima T, Taniguchi R, Kitagawa T, et al.: Headaches in dementia. Headache.1990; 30(11): 735-738.
9.
Kunz M, Lautenbacher S: The impact of Alzheimer's disease on the pain processing. Fortschr Neurol Psychiatr. 2004; 72(7): 375-382.
10.
D'Amato RJ, Zweig RM, Whitehouse PJ, et al.: Aminergic systems in Alzheimer's disease and Parkinson's disease. Ann Neurol. 1987; 22(2): 229-236.
11.
Ebinger G, Bruyland M, Martin JJ: Distribution of biogenic amines and their catabolites in brains from patients with Alzheimer's disease. J Neurol Sci.1987; 77(2-3): 267-283.
12.
Geda Y, Rummans T: Pain: Cause of agitation in elderly individuals with dementia. Am J Psychiatry.1999; 156(10): 1662-1663.
13.
Olson J: Problem behavior or pain? Untreated pain can lead residents with dementia to strike out. Contemp Longterm Care.2000; 23(1): 31-31.
14.
Fisher-Morris M, Gellatly A: The experience and expression of pain in Alzheimer's patients. Age Ageing.1997; 26(6): 497-497.
15.
Weiner D, Peterson B, Ladd K, et al.: Pain in nursing home residents: An exploration of prevalence, staff perspectives, and practical aspects of measurement. Clin J Pain. 1999; 15(2): 461-461.
16.
Carey SJ, Turpin C, Smith J, et al.: Improving pain management in an acute care setting. The Crawford Long Hospital of Emory University experience. Orthop Nurs.1997; 16(4): 29-29.
17.
Melzack R: The McGill Pain Questionnaire: Major properties and scoring methods. Pain. 1975; 1(3): 275-295.
18.
Wong D, Baker C: Pain in children: Comparison of assessment scales. Pediatr Nurs. 1988; 14(1): 9-17.
19.
Bieri D, Reeve R, Champion GD, et al.: The Faces Pain Scale for the self-assessment of severity of pain experienced by children: Initial validation and preliminary investigation for ratio scale properties. Pain. 1990; 41(2): 139-150.
20.
Hurley AC, Volicer BJ, Hanrahan PA, et al.: Assessment of discomfort in advanced Alzheimer's patients. Res Nurs Health Care.1992; 15(5): 369-377.
21.
Simons W, Malabar R: Assessing pain in the elderly patient who cannot respond verbally. J Adv Nurs.1995; 22(4): 663-669.
22.
Kovach C, Weissman D, Griffie J, et al.: Assessment and treatment of discomfort for people with late-stage dementia. J Pain Symptom Manage.1999; 18(6): 412-419.
23.
Marzinski LR: The tragedy of dementia: Clinically assessing pain in the confused nonverbal elderly. J Gerontol Nurs.1991; 17(6): 25-28.
24.
Mamdani M, Rochon PA, Juurlink DN, et al.: Observational study of upper gastrointestinal haemorrhage in elderly patients given selective cyclo-oxygenase-2 inhibitors or conventional non-steroidal antiinflammatory drugs. BMJ.2002; 325(7365): 624-624.
25.
Nietert P, Ornstein S, Dickerson L: Comparison of changes in blood pressure measurements and antihypertensive therapy in older, hypertensive, ambulatory care patients prescribed celecoxib or rofecoxib. Pharmacotherapy.2003; 23(11): 1416-1423.
Porter J, Jick H: Addiction rare in patients treated with narcotics. N Engl J Med.1980; 302(2): 123-123.
28.
World Health Organization: Cancer Pain Relief: With a Guide to Opioid Availability. Geneva: World Health Organization, 1996.
29.
Joranson D, Ryan K, Gilson A, et al.: Trends in medical use and abuse of opioid analgesics. JAMA. 2000; 283(13): 1710-1714.
30.
Portenoy R, Farkash A: Practical management of non-malignant pain the elderly. Geriatrics. 1988; 43(5): 29-40, 44-47.
31.
Robinson CB, Fritch M, Hullett L, et al.: Development of a protocol to prevent opioid-induced constipation in patients with cancer: A research utilization project. Clin J Oncol Nurs.2000; 4(2): 79-84.
32.
Lederle FA, Busch DL, Mattox KM: Cost-effective treatment of constipation in the elderly: A randomized double-blind comparison of sorbidol and lactulose. Am J Med.1990; 89(5): 597-601.
33.
Ensrud KE, Blackwell T, Mangione CM, et al.: Central nervous system active medications and risk for fractures in older women. Arch Intern Med. 2003; 163(8): 949-957.
34.
Short RI, Griffin MR, Daugherty JR, et al.: Opioid analgesics and the risk of hip fracture in the elderly: Codeine and propoxyphene. J Gerontol. 1992; 47(4): M111-M115.
35.
Slatkin N, Rhiner M: Treatment of opioid-induced delirium with acetylcholinesterase inhibitors: A case report. J Pain Symptom Manage. 2004; 27(3): 268-273.
36.
Morrison RS, Magaziner J, Gilbert M, et al.: Relationship between pain and opioid analgesics on the development of delirium following hip fracture. J Gerontol A Biol Sci Med Sci.2003; 58(1): 76-81.
37.
Pain. In Beers M, Berkow R (eds.): The Merck Manual of Geriatrics.Whitehouse Station, NJ: Merck Research Laboratories, 2000: 383-396.
38.
Ventafridda V, Tamburini M, Caraceni A, et al.: A validation study of the WHO method for cancer pain relief. Cancer.1987; 59(4): 850-856.
39.
Silverfield JC, Kamin M, Wu SC, et al.: Tramadol/acetaminophen combination tablets for the treatment of osteoarthritis flare pain: A multicenter, outpatient, randomized, double-blind, placebo-controlled, parallel-group, add-on study. Clin Ther.2002; 24(2): 282-297.
40.
Ytterberg SR, Mahowald ML, Woods SR: Codeine and oxycodone use in patients with chronic rheumatic disease pain. Arthritis Rheum. 1998; 41(9): 1603-1612.
41.
Schnitzer TJ, Gray WL, Paster RZ, et al.: Efficacy of tramadol in the treatment of chronic low back pain. J Rheumatol.2000; 27(3): 772-778.
42.
Ruoff GE, Rosenthal N, Jordan D, et al.: Tramadolacetaminophen combination tablets for the treatment of chronic lower back pain: A multicenter, randomized, double-blind, placebo-controlled outpatient study. Clin Ther.2003; 25(4): 1123-1141.
43.
Ringe J, Faber H, Bock O, et al.: Transdermal fentanyl for the treatment of back pain caused by vertebral osteoporosis. Rheumatol Int.2002; 22(5): 199-203.
44.
Schmader KE: Epidemiology and impact on quality of life of postherpetic neuralgia and painful diabetic neuropathy. Clin J Pain. 2002; 18(6): 350-354.
45.
Bowsher D: The lifetime occurrence of Herpes zoster and prevalence of post-herpetic neuralgia: A retrospective survey in an elderly population. Eur J Pain.1999; 3(4): 335-342.
46.
Watson C, Babul N: Efficacy of oxycodone in neuropathic pain: A randomized trial in postherpetic neuralgia. Neurology.1998; 50(6): 1837-1841.
47.
Harati Y, Gooch C, Swenson M, et al.: Double-blind randomized trial of tramadol for the treatment of the pain of diabetic neuropathy. Neurology.1998; 50(6): 1842-1846.
48.
Harati Y, Gooch C, Swenson M, et al.: Maintenance of the longterm effectiveness of tramadol in the treatment of the pain of diabetic neuropathy. J Diabetes Complications. 2000; 14(2): 65-70.
49.
Raja SN, Haythornthwaite JA, Pappagallo M, et al.: Opioids versus antidepressants in postherpetic neuralgia: A randomized, placebo-controlled trial. Neurology.2002; 59(7): 1015-1021.
50.
Rowbotham MC, Twilling L, Davies PS, et al.: Oral opioid therapy for chronic peripheral and central pain. N Engl J Med.2003; 348(13): 1223-1232.
51.
Collins SL, Moore RA, McQuay HJ, et al.: Antidepressants and anticonvulsants for diabetic neuropathy and postherpetic neuralgia: A quantitative systematic review. J Pain Symptom Manage. 2000; 20(6): 449-458.
52.
Lu CJ, Tune LE: Chronic exposure to anticholinergic medications adversely affects the course of Alzheimer disease. Am J Geriatr Psychiatry.2003; 11(4): 458-461.
53.
Campbell FG, Graham JG, Zilkha KJ: Clinical trial of carbazepine (tegretol) in trigeminal neuralgia. J Neurol Neurosurg Psychiatry.1966; 29(3): 265-267.
54.
Nicol CF: A four year double-blind study of Tegretol in facial pain. Headache. 1969; 9(1): 54-57.
55.
Ahmad M, Goucke CR: Management strategies for the treatment of neuropathic pain in the elderly. Drugs Aging. 2002; 19(12): 929-945.
56.
Backonja M, Beydoun A, Edwards KR, et al.: Gabapentin for the symptomatic treatment of painful neuropathy in patients with diabetes mellitus: A randomized controlled trial. JAMA. 1998; 280(21): 1831-1836.
57.
Rowbotham M, Harden N, Stacey B, et al.: Gabapentin for the treatment of postherpetic neuralgia: A randomized controlled trial. JAMA.1998; 280(21): 1837-1842.
58.
Neurontin (gabapentin) package insert. New York: Parke-Davis, 1998.
59.
Eisenberg E, Lurie Y, Braker C, et al.: Lamotrigine reduces painful diabetic neuropathy: A randomized, controlled study. Neurology. 2001; 57(3): 505-509.
60.
Vestergaard K, Andersen G, Gottrup H, et al.: Lamotrigine for central poststroke pain: A randomized controlled trial. Neurology. 2001; 56(2): 184-190.
61.
McCleane G: 200 mg daily of lamotrigine has no analgesic effect in neuropathic pain: A randomised, double-blind, placebo controlled trial. Pain. 1999; 83(1): 105-107.
62.
Sindrup SH, Jensen TS: Efficacy of pharmacological treatments of neuropathic pain: An update and effect related to mechanism of drug action. Pain.1999; 83(3): 389-400.
63.
Herman E: Lamotrigine: A depression mood stabiliser. Eur Neuropsychopharmacol.2004; 14(Suppl 2): S89-S93.
